Arrhythmogenic right ventricular dysplasia/cardiomyopathy

Heart & Lung : the Journal of Critical Care
T C Harrison, D Kessler

Abstract

Arrhythmogenic right ventricular dysplasia (ARVD/C) is one cause of death in young adults in the United States, representing approximately 17% of all ARVD/C cases reported. This study presents 2 cases of ARVD/C diagnosed at a central Texas hospital and reviews the literature regarding this disease. The diagnosis, histology, presentation, prognosis, and therapy are addressed because the rare nature of this disease within the United States makes diagnosis and treatment difficult and creates problems of adaptation for the patient. Clinicians must become more familiar with this potentially fatal cardiac disorder that can create vulnerability within a young adult population.

Citations

Jan 31, 2006·Pacing and Clinical Electrophysiology : PACE·Jean-François RouxPaul Khairy
Nov 22, 2007·Advances in Therapy·Mehmet Gungor KayaAtiye Cengel
May 14, 2005·The Nurse Practitioner·Betsy A Wolfe, Elizabeth J Corwin
Mar 20, 2004·Journal of Cardiovascular Electrophysiology·Chandra BommaHugh Calkins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.